Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 2,050.00
+15.00 (0.74%)
At close: Oct 28, 2025
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 375.84 billion as of October 28, 2025. Its market cap has decreased by -13.66% in one year.
Market Cap
375.84B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
38.42
Stock Price
2,050.00
Market Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 375.84B, an increase of 508.13%. That is a compound annual growth rate of 5.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 372.19B | 2.36% |
| Dec 30, 2024 | 363.59B | -6.45% |
| Dec 28, 2023 | 388.65B | -34.62% |
| Dec 29, 2022 | 594.40B | -38.56% |
| Dec 30, 2021 | 967.50B | -34.20% |
| Dec 30, 2020 | 1.47T | 21.27% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 85.98T |
| Celltrion | 39.30T |
| ALTEOGEN | 25.86T |
| SK Biopharmaceuticals | 9.02T |
| Yuhan | 8.94T |
| Peptron | 6.37T |
| HLB Co., Ltd. | 6.06T |
| PharmaResearch | 5.55T |